4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-029040
Director sold 12,195 shares at an average $50.88 ($620,443)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fust Matthew K · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-07 | Sale : show line 1 in the form 10b5-1 | −2,550 | $50.89 | $129,770 | 24,505 | D |
| 2024-03-07 | Sale : show line 2 in the form 10b5-1 | −2,145 | $50.85 | $109,073 | 22,360 | D |
| 2024-03-07 | Sale : show line 3 in the form 10b5-1 | −7,500 | $50.88 | $381,600 | 14,860 | D |
| Open-market sales · 12,195 sh · avg $50.88 · $620,443 | ||||||
Loading xslF345X05/ownership.xml…